CSIMarket
 


Quidel Corporation  (QDEL)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

QDEL's Net Income Growth by Quarter and Year

Quidel's Net Income results by quarter and year




QDEL Net Income (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 470.13 30.63 32.48
III Quarter September - 232.27 16.18 10.82
II Quarter June - 67.65 1.27 -3.08
I Quarter March 178.08 40.24 24.84 33.96
FY   178.08 810.29 72.92 74.18



QDEL Net Income first quarter 2021 Y/Y Growth Comment
Quidel Corporation reported Net Income surge of 342.55% year on year in the first quarter, to $ 178.08 millions, this is lower than Quidel Corporation's recent average Net Income surge of 3696.77%.

Looking into first quarter results within Biotechnology & Drugs industry 2 other companies have achieved higher Net Income growth. While Quidel Corporation' s Net Income doubling of 342.55% ranks overall at the positon no. 250 in the first quarter.




QDEL Net Income ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - 1434.87 % -5.7 % -
III Quarter September - 1335.54 % 49.54 % -
II Quarter June - 5226.77 % - -
I Quarter March 342.55 % 62 % -26.86 % 137.65 %
FY   - 1011.2 % -1.7 % -

Financial Statements
Quidel's first quarter 2021 Net Income $ 178.08 millions QDEL's Income Statement
Quidel's first quarter 2020 Net Income $ 40.24 millions Quarterly QDEL's Income Statement
New: More QDEL's historic Net Income Growth >>


QDEL Net Income (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - 102.41 % 89.31 % 200.18 %
III Quarter September - 243.34 % 1174.02 % -
II Quarter June - 68.12 % -94.89 % -
I Quarter March -62.12 % 31.37 % -23.52 % -
FY (Year on Year)   - 1011.2 % -1.7 % -




Net Income first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #3
Healthcare Sector #17
Overall #250

Net Income Y/Y Growth Statistics
High Average Low
24149.02 % 3696.77 % -99.31 %
(Mar 31 2013)   (Dec 31 2013)
Net Income first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #3
Healthcare Sector #17
Overall #250
Net Income Y/Y Growth Statistics
High Average Low
24149.02 % 3696.77 % -99.31 %
(Mar 31 2013)   (Dec 31 2013)

Net Income by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Quidel's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
1174.09 % 143.82 % -94.89 %
(Sep 30 2019)  


QDEL's I. Quarter Q/Q Net Income Comment
In the I. Quarter 2021 Quidel Corporation reported fall in Net Income sequentially by -62.12% to $ 178.08 millions, from $ 470.13 millions declared in the previous reporting period.

Even cyclical influence which normally elevate I. Quarter 2021 performance, could not recover the I. Quarter for the Quidel Corporation, Aadhya Powar , Healthcare sector observer said and continued that average quarter on quarter Net Income growth is at 143.82% for the Biotechnology & Drugs's company.

Within Biotechnology & Drugs industry 13 other companies have achieved higher Net Income quarter on quarter growth. While Quidel's Net Income growth quarter on quarter, overall rank is 1469.


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #14
Healthcare Sector #97
Overall #1469
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #14
Healthcare Sector #97
Overall #1469
Net Income Q/Q Growth Statistics
High Average Low
1174.09 % 143.82 % -94.89 %
(Sep 30 2019)  


QDEL's I. Quarter Q/Q Net Income Comment
In the I. Quarter 2021 Quidel Corporation realized fall in Net Income sequentially by -62.12% to $ 178.08 millions, from $ 470.13 millions declared in the previous reporting period.

Although periodic influence which normally fuel I. Quarter 2021 performance, it clearly could not be enough to salvage QDEL's outcome, Aadhya Powar , Healthcare sector observer wrote and continued that average sequential Net Income growth is at 143.82% for the Biotechnology & Drugs's company.

Within Biotechnology & Drugs industry 13 other companies have achieved higher Net Income quarter on quarter growth. While Quidel's Net Income growth quarter on quarter, overall rank is 1469.


Quidel's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Net Income 12 Months Ending $ 948.13 $ 810.29 $ 370.78 $ 154.70 $ 88.31
Y / Y Net Income Growth (TTM) 973.59 % 1011.18 % 395.87 % 122.86 % 35.72 %
Year on Year Net Income Growth Overall Ranking # 30 # 9 # 79 # 189 # 398
Seqeuential Net Income Change (TTM) 17.01 % 118.53 % 139.68 % 75.17 % 21.11 %
Seq. Net Income Growth (TTM) Overall Ranking # 929 # 55 # 56 # 131 # 272




Cumulative Net Income growth Comment
Assuming the Quidel's fiscal year would have ended in Mar 31 2021, Quidel would have reprted above average annual Net Income surge of 973.59% year on year, of $ 948 millions.
This marks a slow-down of the companys growth trends and from the 1011.18% surge in Dec 31 2020.

Looking into Healthcare sector trailing twelve month Net Income increase, only one company had higher growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 9 to 30.

Net Income TTM Q/Q Growth Statistics
High Average Low
139.68 %
43.81 %
-61 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 9
Healthcare Sector # 2
Overall # 30

Net Income TTM Y/Y Growth Statistics
High Average Low
1011.18 %
324.91 %
-1.7 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 60
S&P 500 # 929
Cumulative Net Income growth Comment
Assuming the Quidel's fiscal year would have ended in Mar 31 2021, Quidel would have reprted above average annual Net Income surge of 973.59% year on year, of $ 948 millions.
This marks a slow-down of the companys growth trends and from the 1011.18% surge in Dec 31 2020.

Looking into Healthcare sector trailing twelve month Net Income increase, only one company had higher growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 9 to 30.

Net Income TTM Q/Q Growth Statistics
High Average Low
139.68 %
43.81 %
-61 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 9
Healthcare Sector # 2
Overall # 30

Net Income TTM Y/Y Growth Statistics
High Average Low
1011.18 %
324.91 %
-1.7 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 60
S&P 500 # 929




Other Net Income Growth
Biotechnology & Drugs Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
QDEL's Net Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for QDEL's Competitors
Net Income Growth for Quidel's Suppliers
Net Income Growth for QDEL's Customers

You may also want to know
QDEL's Annual Growth Rates QDEL's Profitability Ratios QDEL's Asset Turnover Ratio QDEL's Dividend Growth
QDEL's Roe QDEL's Valuation Ratios QDEL's Financial Strength Ratios QDEL's Dividend Payout Ratio
QDEL's Roa QDEL's Inventory Turnover Ratio QDEL's Growth Rates QDEL's Dividend Comparisons



Companies with similar Net Income surge for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Net Income for the quarter ending Mar 31 2021
Hologic Inc543.72%$ 543.718 millions
Surmodics Inc 453.15%$ 453.146 millions
Bruker Corporation445.28%$ 445.283 millions
Integra Lifesciences Holdings Corp394.49%$ 394.488 millions
Apollo Medical Holdings Inc 384.03%$ 384.031 millions
Quest Diagnostics Inc362.26%$ 362.264 millions
Quidel Corporation342.59%$ 342.588 millions
Pacific Health Care Organization Inc312.00%$ 311.998 millions
Progyny Inc 273.82%$ 273.823 millions
U S Physical Therapy Inc256.08%$ 256.081 millions
Avantor Inc 248.94%$ 248.936 millions
Kintara Therapeutics Inc 239.25%$ 239.247 millions
Teva Pharmaceutical Industries Ltd236.00%$ 236.000 millions
Abbott Laboratories217.91%$ 217.908 millions
U s Neurosurgical Holdings Inc 208.00%$ 208.000 millions
Repligen Corp200.05%$ 200.051 millions
Reynolds Consumer Products Inc 184.62%$ 184.615 millions
Meridian Bioscience Inc 181.03%$ 181.034 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SWN's Profile

Stock Price

SWN's Financials

Business Description

Fundamentals

Charts & Quotes

SWN's News

Suppliers

SWN's Competitors

Customers & Markets

Economic Indicators

SWN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071